TruSight Oncology Comprehensive (EU)
The first CE-marked IVD kitted solution for comprehensive genomic profiling (CGP) of DNA and RNA variants, plus MSI and TMB, for multiple solid tumor types.
VeriSeq NIPT Solution v2
Comprehensive in-lab NIPT IVD solution including reagents, instruments, and software for accurate aneuploidy screening results in 26 hours.
Illumina DNA Prep with Enrichment Dx
A library preparation and enrichment solution for IVD targeted sequencing applications.
MiSeqDx Reagent Kit v3
A validated, FDA-regulated, CE-marked IVD sequencing reagent kit, offering improved quality scores compared to previous versions.
NextSeq 550Dx Reagents
These sequencing reagent kits offer a simplified workflow and high data quality for in vitro diagnostic testing on the NextSeq550 Dx Instrument.
NovaSeq 6000Dx Reagent Kits
These sequencing reagent kits allow clinical laboratories to perform high-throughput in vitro diagnostic testing on the NovaSeq 6000Dx instrument.
Pillar oncoReveal CDx
Pillar oncoReveal CDx is an FDA-approved, NGS-based companion diagnostic kit detecting variants in 22 clinically significant genes in solid tumor DNA.
Assay time: 48 hrs
Hands-on time: 3.5 hr
Input quantity: 30–80 ng DNA
TruSeq Custom Amplicon Kit Dx
A validated, FDA-regulated kit enabling clinical laboratories to design their own next-generation sequencing assays for use on the MiSeqDx and NextSeq 550Dx systems.
TruSight Cystic Fibrosis
FDA-regulated, CE-marked in vitro diagnostic (IVD) next-generation sequencing assay conveniently providing two cystic fibrosis tests in one product.
TruSight Oncology Comprehensive (EU)
The first CE-marked IVD kitted solution for comprehensive genomic profiling (CGP) of DNA and RNA variants, plus MSI and TMB, for multiple solid tumor types.
TruSight Oncology Comprehensive
The first US FDA-approved distributable comprehensive genomic profiling (CGP) IVD with pan-cancer companion diagnostic (CDx) claims.
Assay time: 4-5 days
Hands-on time: ~10.5 hr
Input quantity: 40 ng genomic DNA
TruSight Whole Genome
An EU IVDR 2017/746-compliant, scalable whole-genome sequencing solution for clinical diagnostic testing.
VeriSeq NIPT Solution v2
Comprehensive in-lab NIPT IVD solution including reagents, instruments, and software for accurate aneuploidy screening results in 26 hours.
Designed, validated, and regulated for clinical use, Illumina in vitro diagnostic (IVD) products include sequencing instruments, assays, library prep kits, and software.
Available in > 45 countries, the MiSeqDx is an in vitro diagnostic (IVD) next-generation sequencing instrument for diagnostics and clinical research.
Regulated platforms with stringent performance characteristics for diagnostic use.
Next-generation sequencing panels for detection of causative and clinically relevant variants for cystic fibrosis.